(Press-News.org) Scientists have developed a tool that can predict how bowel cancer adapts to treatment – helping researchers to design new personalised drugs that will keep patients living well for longer.
A team from the Institute of Cancer Research, London, and Queen Mary University of London have designed a new technology that uses evolutionary biology to measure and predict how cancer cells will evolve when they are exposed to a new treatment.
Bowel cancer is the fourth most common cancer in the UK. There are around 44,100 new bowel cancer cases in the UK every year, or around 120 every day. Most bowel cancers are treated with chemotherapies and these treatments haven’t changed in almost 50 years.
Patients with late-stage disease typically die from drug resistance – when the cancer stops responding to treatment.
Drug resistance is caused by molecular changes in cancer cells that renders the treatment ineffective. Understanding exactly how this resistance develops will allow researchers design new and better drugs that target the mechanisms of resistance – ensuring cancer is kept at bay for longer. It will also allow clinicians to use existing drugs in the optimal way – altering doses if necessary.
There are two routes that cancer cells can take to escape a drug’s action, but until now, it has been very hard to tell them apart.
In research published in the journal Nature Communications, the team from the Centre for Evolution and Cancer at The Institute of Cancer Research (ICR), and funded by the Wellcome Trust and Cancer Research UK, tracked bowel cancer cells as they evolved resistance to chemotherapy.
Together with colleagues from Queen Mary University of London, the researchers used mathematical modelling to pinpoint when resistance to the drug developed. They could then determine whether resistance was caused by a rare genetic mutation in one cell that was copied as the cell divided, or whether there was a non-genetic change responsible.
The researchers have now turned their method, called EIRAs (Evolutionary Informed Resistance Assays), into a tool that can be adopted into the process of developing new medicines. By using EIRAS, they hope that new personalised drugs can be designed which target the route that a patients’ tumour has taken to evolve resistance.
The researchers are seeking commercial partners to further progress this work, as well as working with colleagues in the ICR’s Centre for Cancer Drug Discovery. A patent has been submitted for the technology, which the researchers believe could be used to support the development of a number of cancer drugs – they have already begun exploring its use for ovarian and breast cancer.
Professor Trevor Graham, Professor of Genomics and Evolution and Director of the Centre for Evolution and Cancer at The Institute of Cancer Research, London, said:
“Just like bacteria evolve resistance to antibiotics, cancer cells can evolve resistance to chemotherapy, making treatment less effective. This treatment resistance is a long-standing problem that we are desperate to solve. Cancers may respond well for a while, but sadly then they usually become resistant and the drug stops working.
“By studying bowel cancer cells over time as we treat them with chemotherapy, we have been able to develop a machine learning technology that can unpick how and when these cells become resistant. We hope this information will allow us to design new, personalised drugs – ones that target these changes so that the cancer responds to treatment. We also believe we can use the technology to learn how to alter the dose of existing drugs, to keep them working for longer.
“I’m excited to work with colleagues and partners – including those in the ICR’s Centre for Cancer Drug Discovery – to implement this technology, and to bring more treatment options to patients living with cancer.”
Professor Kristian Helin, Chief Executive of The Institute of Cancer Research, London, said:
“As cancer researchers, we are constantly searching for ways to halt cancer’s growth when treatments stop working. This work will help us to identify new targets to tackle cancer once resistance develops.
“The research brings together ideas in machine learning, cancer evolution, and drug discovery. The Institute of Cancer Research has an unrivalled track record of drug discovery, and I look forward to seeing this technology progress, through our Centre for Cancer Drug Discovery and through collaborations with partners, to drive the development of treatments that benefit patients for even longer.”
Professor Richard Nichols, Professor of Evolutionary Genetics in the School of Biological and Behavioural Sciences at Queen Mary University London, said:
“These advances have come from treating cancer cells’ resistance to chemotherapy as a question about evolution. We asked whether their resistance has a genetic basis, building on methods that were first developed to resolve disputes among biologists about the colour patterns of snails. The success of this project shows the value of cross-fertilization of ideas, sometimes between subject areas that seem distantly related.”
END
Scientists find new way to predict how bowel cancer drugs will stop working – paving the way for smarter treatments
2025-06-20
ELSE PRESS RELEASES FROM THIS DATE:
Breast cancer patients’ microbiome may hold key to avoiding damaging heart side-effects of cancer therapies
2025-06-20
New research suggests that a healthy microbiome before chemotherapy could help protect breast cancer patients against heart damage, or cardiotoxicity, as a result of cancer therapy.
Researchers found that specific bacteria in patients’ gut microbiome correlated with heart health biomarkers that suggest they are at greater risk of heart damage during chemotherapy.
“To allow cancer survivors healthier lives, we need to find new ways to protect them from the long-term side-effects of chemotherapy. This study is one of the first to ask whether the microbiome could play a role in how well patient’s hearts fare during chemotherapy,” ...
Exercise-induced protein revives aging muscles and bones
2025-06-20
“Exercise is good for your health” is a well-known phrase, but few people can clearly explain how and why it benefits the human body.”
A joint research team, led by Dr. Yong Ryoul Yang of the Aging Convergence Research Group at the Korea Research Institute of Bioscience and Biotechnology (KRIBB, President: Seok-Yoon Kwon) and Professor Nak-Sung Kim of Chonnam National University, has discovered a key protein, CLCF1 (cardiotrophin-like cytokine factor 1), that plays a central role in mediating the health benefits of physical activity.
The team found that CLCF1 is secreted by muscles during exercise, where it helps strengthen both muscles and bones, thereby ...
American College of Cardiology issues guidance on weight management drugs
2025-06-20
The American College of Cardiology has issued a Concise Clinical Guidance (CCG) document to aid clinicians in the use of medication for weight management in patients where treatment may provide cardiovascular benefit.
Obesity is a chronic, progressive disease that affects over 1 billion people worldwide. It can lead to devastating cardiovascular complications, including increased risk of heart failure, coronary artery disease and stroke. It is also associated with a significant reduction in life expectancy (9.1 years ...
Understanding the effect of bedding on thermal insulation during sleep
2025-06-20
The temperature of our sleeping environment has a major impact on the quality of our sleep, and good sleep is essential for our overall health and well-being. The bedding micro-environment is a key factor in maintaining thermally comfortable conditions for sleep. This includes the ambient temperature, humidity, the heat generated by the human body, and the thermal insulation provided by bedding like quilts, blankets, sheets, etc.
In particular, the total thermal insulation, or the ability of the bedding systems to resist heat flow, ...
Cosmic signal from the very early universe will help astronomers detect the first stars
2025-06-20
Understanding how the universe transitioned from darkness to light with the formation of the first stars and galaxies is a key turning point in the universe’s development, known as the Cosmic Dawn. However, even with the most powerful telescopes, we can’t directly observe these earliest stars, so determining their properties is one of the biggest challenges in astronomy.
Now, an international group of astronomers led by the University of Cambridge have shown that we will be able to learn about the masses ...
With AI, researchers find increasing immune evasion in H5N1
2025-06-20
Highlights:
H5N1 avian influenza virus has been found in mammals and birds, and 1 person in the U.S. has died from an infection.
New work suggests that the virus is evolving new ways to evade human immune defenses.
Using artificial intelligence and physics-based modeling, the researchers found weakening binding between defensive antibodies and viral proteins.
The work shows how AI may help researchers understand how the virus is evolving and look for new antibodies or other therapeutic interventions.
Los Angeles, Calif.—The H5N1 avian influenza virus has infected birds and mammals around ...
Study finds hidden effects of wildfires on water systems
2025-06-20
Highlights:
Wildfires disrupt microbial communities on land, but also alter aquatic systems when dissolved organic matter on burnt lands is carried into rivers, lakes or drinking water supplies.
In a new study, researchers found that the impact of wildfires on water systems could lead to nutrient imbalances, depleting oxygen levels or harmful algal blooms.
More complex treatment methods may be needed to ensure impacted water is safe for consumption or recreation.
Los Angeles, Calif.—Wildfires profoundly influence the unseen microbial world within our waters, directly impacting water quality and ecosystem health, according to a new study ...
Airborne fungal spores may help predict COVID-19 & flu surges
2025-06-20
Highlights:
A new study identified that increased levels of fungal spores in the air were strongly linked to surges in cases of influenza and COVID-19.
Monitoring airborne fungal spores could help predict surges of respiratory virus infections, providing an early warning system to public health systems.
Los Angeles, Calif.—Monitoring fungal spores in the outdoor air can predict surges in flu and COVID-19 infections, especially during the fall, according to a new study. The study is presented at ASM Microbe ...
Study shows tissues’ pliability depends on watery fluid between cells
2025-06-20
Water makes up around 60 percent of the human body. More than half of this water sloshes around inside the cells that make up organs and tissues. Much of the remaining water flows in the nooks and crannies between cells, much like seawater between grains of sand.
Now, MIT engineers have found that this “intercellular” fluid plays a major role in how tissues respond when squeezed, pressed, or physically deformed. Their findings could help scientists understand how cells, tissues, and organs ...
Interfacial polymer cross-linking strategy enables ultra-thin polymeric membranes for fast and selective ion transport
2025-06-20
Polymeric membranes are widely used in separation technologies due to their low cost and easily scalable fabrication. However, unlike inorganic nanoporous materials such as metal-organic frameworks and covalent organic frameworks, which feature periodic and ordered channels, polymeric membranes produced through traditional methods—such as phase separation—typically have irregular and disordered pore structures. This structural limitation makes it difficult to accurately separate ions or molecules ...